Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
GKL-006 Combined With TACE in Treatment of Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Safety and Efficacy of Atezolizumab-Bevacizumab Versus Tyrosin Kinase Inhibitors in Patients With Liver Cirrhosis
- Status
- COMPLETED
- Phase
- N/A
Enhanced Radiofrequency Ablation for Recurrent HCC Post-TACE Using Twin Internally Cooled-Perfusion Electrodes
- Status
- COMPLETED
- Phase
- NA
Immunogenomic Dynamics and Biomarkers in Patients With Hepatocellular Carcinoma Receiving Immunotherapy
- Status
- RECRUITING
- Phase
- N/A
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib：A Prospective, Single-arm, Multicenter, Observational Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Effects of Antrodia Cinnamomea on the Hepatoma Patients After Transcatheter Hepatic Artery Chemoembolization
- Status
- RECRUITING
- Phase
- NA
A Study of ZW251 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
ThinkRadial: A Prospective Study of Transradial deTACE in HCC Patients
- Status
- COMPLETED
- Phase
- N/A
The Safety, Efficacy, and Immune Response of Multimodal Thermal Therapy in the Treatment of Malignant Liver Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Gecacitinib Combined With Donafenib and PD-1 Inhibitor as Immune Rechallenge Therapy for Unresectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
- Status
- RECRUITING
- Phase
- PHASE1
Y-90 Treatment Response Using Transarterial Radioembolization
- Status
- RECRUITING
- Phase
- PHASE2
A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
AHCC® as Immune Modulator in Cancer Patients Treated With Immunotherapy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- Status
- RECRUITING
- Phase
- PHASE1
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1
Yttrium-90 Radiation Segmentectomy for Hepatocellular Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- NA
TACE Combined With Anti-PD-1 Antibody in Patients With Advanced Hepatocellular Carcinoma: Study on Efficacy and Immune Microenvironment
- Status
- RECRUITING
- Phase
- N/A